NPI: 1831173467 · FRANKLIN, KY 42134 · Critical Access Hospital · NPI assigned 12/06/2005
Authorized official LAWLESS, MICHELE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWLESS, MICHELE (EXECUTIVE VICE PRESIDENT & CFO) |
| NPI Enumeration Date | 12/06/2005 |
Other providers sharing the same authorized official: LAWLESS, MICHELE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 29,104 | $1.67M |
| 2019 | 28,991 | $1.47M |
| 2020 | 30,634 | $1.72M |
| 2021 | 38,135 | $2.34M |
| 2022 | 40,240 | $2.69M |
| 2023 | 36,662 | $2.50M |
| 2024 | 12,586 | $829K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 10,707 | 8,624 | $2.88M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5,940 | 4,227 | $2.08M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,735 | 1,390 | $1.80M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 7,566 | 6,580 | $1.23M |
| 70450 | Computed tomography, head or brain; without contrast material | 1,956 | 1,521 | $630K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,108 | 929 | $509K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,187 | 3,349 | $308K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4,473 | 3,921 | $307K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 8,280 | 4,258 | $303K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,191 | 3,291 | $216K |
| 36415 | Collection of venous blood by venipuncture | 24,212 | 12,767 | $211K |
| 71045 | Radiologic examination, chest; single view | 4,093 | 3,401 | $205K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,619 | 1,548 | $178K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4,345 | 3,247 | $165K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,490 | 493 | $129K |
| 80053 | Comprehensive metabolic panel | 12,593 | 9,134 | $129K |
| 71046 | Radiologic examination, chest; 2 views | 1,598 | 1,320 | $120K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3,205 | 2,673 | $106K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,678 | 2,228 | $100K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14,577 | 11,441 | $96K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3,306 | 2,928 | $94K |
| V2632 | Posterior chamber intraocular lens | 557 | 262 | $78K |
| J7050 | Infusion, normal saline solution, 250 cc | 4,903 | 2,567 | $66K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,620 | 2,093 | $59K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,893 | 2,946 | $58K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 457 | 417 | $53K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 869 | 809 | $44K |
| 84443 | Thyroid stimulating hormone (TSH) | 3,048 | 2,731 | $43K |
| 84484 | 4,005 | 3,140 | $41K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 343 | 278 | $41K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,107 | 812 | $38K |
| C1780 | Lens, intraocular (new technology) | 214 | 111 | $38K |
| 83880 | 1,282 | 1,080 | $34K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 483 | 426 | $33K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4,586 | 3,534 | $33K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 141 | 92 | $31K |
| 80061 | Lipid panel | 2,067 | 1,903 | $30K |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,433 | 1,342 | $29K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,195 | 838 | $28K |
| 73630 | 284 | 209 | $27K | |
| 83690 | 4,109 | 3,332 | $27K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,579 | 1,101 | $26K |
| 80306 | 1,849 | 1,546 | $26K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,931 | 1,591 | $25K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 319 | 305 | $24K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,019 | 930 | $24K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,603 | 3,036 | $21K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 269 | 206 | $19K |
| 87631 | 194 | 163 | $18K | |
| 84703 | 2,374 | 2,029 | $17K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,316 | 1,757 | $17K |
| 85379 | 1,793 | 1,541 | $15K | |
| J2704 | Injection, propofol, 10 mg | 792 | 541 | $15K |
| 81015 | 3,763 | 3,115 | $14K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 32 | 26 | $13K |
| 85730 | 2,318 | 1,985 | $13K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,748 | 1,533 | $12K |
| 94664 | 1,153 | 851 | $12K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,029 | 702 | $12K |
| 82150 | 1,917 | 1,537 | $12K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 394 | 105 | $12K |
| 93971 | 52 | 48 | $11K | |
| 84145 | 534 | 438 | $10K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 306 | 260 | $10K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 39 | 26 | $10K |
| 83605 | 1,051 | 801 | $10K | |
| 85610 | 2,918 | 2,392 | $9K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 84 | 62 | $9K |
| 81003 | 3,150 | 2,721 | $9K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 16 | 14 | $8K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 320 | 26 | $8K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 425 | 333 | $8K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 152 | 139 | $8K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 327 | 256 | $7K |
| J2550 | Injection, promethazine hcl, up to 50 mg | 575 | 400 | $7K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 291 | 109 | $7K |
| 85027 | 750 | 653 | $6K | |
| 87040 | 589 | 429 | $6K | |
| 83735 | 1,136 | 917 | $6K | |
| 76830 | Ultrasound, transvaginal | 35 | 29 | $5K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 396 | 291 | $5K |
| 82553 | 336 | 284 | $5K | |
| 82948 | 605 | 355 | $5K | |
| 80076 | 700 | 585 | $5K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 382 | 329 | $5K |
| 86140 | 1,133 | 941 | $5K | |
| 82550 | 610 | 476 | $4K | |
| 82607 | 324 | 289 | $4K | |
| 87634 | 93 | 90 | $4K | |
| 85651 | 1,121 | 923 | $3K | |
| 74018 | 33 | 26 | $3K | |
| J3490 | Unclassified drugs | 224 | 131 | $3K |
| 87486 | 121 | 91 | $3K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 14 | 12 | $3K |
| 87581 | 114 | 90 | $2K | |
| 87186 | 252 | 223 | $2K | |
| 36600 | 73 | 39 | $2K | |
| 90715 | 93 | 82 | $2K | |
| 84439 | 295 | 265 | $2K | |
| Q3014 | Telehealth originating site facility fee | 135 | 12 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 79 | 70 | $2K |
| C9113 | Injection, pantoprazole sodium, per vial | 133 | 80 | $2K |
| 73562 | 19 | 12 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 200 | 86 | $2K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 138 | 106 | $2K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 89 | 76 | $1K |
| 81001 | 357 | 298 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 60 | 40 | $792.91 |
| 82803 | 56 | 42 | $782.10 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 12 | 12 | $672.98 |
| 82805 | 14 | 12 | $655.01 | |
| 87070 | 79 | 67 | $491.47 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 64 | 49 | $456.26 |
| 82375 | 55 | 42 | $441.26 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 20 | 13 | $440.45 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 32 | 28 | $354.27 |
| 82728 | 34 | 28 | $338.53 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 14 | 12 | $217.60 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 15 | 14 | $182.40 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 15 | 14 | $182.40 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 15 | 14 | $182.40 |
| 85018 | 84 | 67 | $150.45 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 22 | 18 | $143.68 |
| 87081 | 21 | 17 | $133.90 | |
| 86308 | 27 | 26 | $132.18 | |
| 82010 | 13 | 12 | $105.77 | |
| 86900 | 17 | 13 | $54.52 | |
| 86901 | 17 | 13 | $54.52 |